Robert Wilson to Female
This is a "connection" page, showing publications Robert Wilson has written about Female.
Connection Strength
0.215
-
Update on the prenatal diagnosis and treatment of congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2005 Feb; 18(2):133-42.
Score: 0.014
-
In vitro expression studies of a novel mutation delta299 in a patient affected with apparent mineralocorticoid excess. J Clin Endocrinol Metab. 2004 May; 89(5):2024-7.
Score: 0.013
-
Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis. Clin Epigenetics. 2023 02 17; 15(1):25.
Score: 0.012
-
Prenatal diagnosis for congenital adrenal hyperplasia in 532 pregnancies. J Clin Endocrinol Metab. 2001 Dec; 86(12):5651-7.
Score: 0.011
-
Apparent mineralocorticoid excess. Trends Endocrinol Metab. 2001 Apr; 12(3):104-11.
Score: 0.010
-
Prevalence of mild apparent mineralocorticoid excess in Mennonites. J Clin Endocrinol Metab. 1999 Dec; 84(12):4735-8.
Score: 0.009
-
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12790-7.
Score: 0.009
-
Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia. J Clin Endocrinol Metab. 1999 Sep; 84(9):3129-34.
Score: 0.009
-
Inhibition of the transcriptional kinase CDK7 overcomes therapeutic resistance in HER2-positive breast cancers. Oncogene. 2020 01; 39(1):50-63.
Score: 0.009
-
Congenital adrenal hyperplasia (21-hydroxylase deficiency) without demonstrable genetic mutations. J Clin Endocrinol Metab. 1999 Jan; 84(1):378-81.
Score: 0.009
-
A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A. 1998 Aug 18; 95(17):10200-5.
Score: 0.009
-
Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11?-hydroxysteroid dehydrogenase type 2 deficiency. Proc Natl Acad Sci U S A. 2017 12 26; 114(52):E11248-E11256.
Score: 0.008
-
A novel mutation in HSD11B2 causes apparent mineralocorticoid excess in an Omani kindred. Ann N Y Acad Sci. 2016 07; 1376(1):65-71.
Score: 0.008
-
Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
Score: 0.007
-
Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA. BMC Genomics. 2016 Mar 31; 17:263.
Score: 0.007
-
Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia. J Steroid Biochem Mol Biol. 2017 01; 165(Pt A):51-56.
Score: 0.007
-
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
Score: 0.007
-
FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13.
Score: 0.007
-
Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
Score: 0.007
-
KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
Score: 0.007
-
Isolated mild clitoral hypertrophy may reveal 46,XY disorders of sex development in infancy due to 17?HSD-3 defect confirmed by molecular analysis. Gynecol Endocrinol. 2011 Nov; 27(11):890-4.
Score: 0.005
-
CYP21A2 gene mutations in congenital adrenal hyperplasia: genotype-phenotype correlation in Turkish children. J Clin Res Pediatr Endocrinol. 2009; 1(3):116-28.
Score: 0.004
-
Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2007 Jan; 92(1):137-42.
Score: 0.004
-
Two novel mutations found in a patient with 17alpha-hydroxylase enzyme deficiency. J Clin Endocrinol Metab. 2006 Oct; 91(10):4179-82.
Score: 0.004
-
Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency). J Mol Diagn. 2005 May; 7(2):236-46.
Score: 0.003
-
Nonclassic 21-hydroxylase deficiency in Croatia. J Pediatr Endocrinol Metab. 2004 Feb; 17(2):157-64.
Score: 0.003
-
Resistance to multiple steroids in two sisters. J Steroid Biochem Mol Biol. 2001 Jan-Mar; 76(1-5):161-6.
Score: 0.003
-
Profile of the pediatric endocrine clinic at New York-Presbyterian Hospital, New York Weill Cornell Center. J Clin Endocrinol Metab. 1999 Dec; 84(12):4444-9.
Score: 0.002
-
Resistance to several steroids in two sisters. J Clin Endocrinol Metab. 1999 Dec; 84(12):4454-64.
Score: 0.002
-
Intrauterine growth retardation associated with maternal uniparental disomy for chromosome 6 unmasked by congenital adrenal hyperplasia. Pediatr Res. 1999 Nov; 46(5):510-3.
Score: 0.002
-
Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment. J Steroid Biochem Mol Biol. 1999 Apr-Jun; 69(1-6):19-29.
Score: 0.002